Literature DB >> 16899594

Induction of interleukin-6 by hepatitis C virus core protein in hepatitis C-associated mixed cryoglobulinemia and B-cell non-Hodgkin's lymphoma.

Georg Feldmann1, Hans Dieter Nischalke, Jacob Nattermann, Brigitte Banas, Thomas Berg, Christian Teschendorf, Wolff Schmiegel, Ulrich Dührsen, Juliane Halangk, Agathe Iwan, Tilman Sauerbruch, Wolfgang H Caselmann, Ulrich Spengler.   

Abstract

PURPOSE: Chronic hepatitis C carries the risk to develop mixed cryoglobulinemia (MC) and B-cell non-Hodgkin's lymphoma (B-NHL), possibly because viral antigens stimulate the host's inflammatory response via extracellular pattern recognition receptors (PRR). To clarify this issue, we studied whether recognition of hepatitis C virus (HCV) proteins by PRR is involved in the pathogenesis of HCV-associated MC or B-NHL. EXPERIMENTAL
DESIGN: Peripheral blood mononuclear cells of patients with HCV-associated B-NHL (n = 12), MC (n = 14), uncomplicated hepatitis C (n = 12), and healthy volunteers (n = 12) were incubated with the recombinant HCV proteins E2, core, and NS3 to study induction of cytokine production, stimulation of B-cell proliferation, and immunoglobulin secretion. In addition, serum levels of interleukin-6 (IL-6) were measured by ELISA.
RESULTS: HCV core was the only studied protein, which induced production of IL-6 and IL-8 in CD14(+) cells. IL-6 induction was mediated via Toll-like receptor 2 (TLR2) and lead to increased B-cell proliferation in vitro. TLR2 expression on monocytes and IL-6 serum concentrations were increased in all groups of HCV-infected patients compared with healthy controls and were highest in MC (P < 0.05).
CONCLUSIONS: Increased secretion of IL-6 via stimulation of TLR2 by HCV core protein may play a role in the pathogenesis of hepatitis C-associated MC and B-NHL.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16899594     DOI: 10.1158/1078-0432.CCR-06-0154

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  23 in total

Review 1.  Hepatitis C virus-associated B-cell non-Hodgkin's lymphomas: what do we know?

Authors:  Barbara Vannata; Luca Arcaini; Emanuele Zucca
Journal:  Ther Adv Hematol       Date:  2015-12-29

2.  Impact of DAA-Based Regimens on HCV-Related Extra-Hepatic Damage: A Narrative Review.

Authors:  Evangelista Sagnelli; Caterina Sagnelli; Antonio Russo; Mariantonietta Pisaturo; Clarissa Camaioni; Roberta Astorri; Nicola Coppola
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  Persistent expression of the full genome of hepatitis C virus in B cells induces spontaneous development of B-cell lymphomas in vivo.

Authors:  Yuri Kasama; Satoshi Sekiguchi; Makoto Saito; Kousuke Tanaka; Masaaki Satoh; Kazuhiko Kuwahara; Nobuo Sakaguchi; Motohiro Takeya; Yoichi Hiasa; Michinori Kohara; Kyoko Tsukiyama-Kohara
Journal:  Blood       Date:  2010-08-23       Impact factor: 22.113

4.  Toll-like receptor 2 senses hepatitis C virus core protein but not infectious viral particles.

Authors:  Marco Hoffmann; Mirjam B Zeisel; Nikolaus Jilg; Glaucia Paranhos-Baccalà; Françoise Stoll-Keller; Takaji Wakita; Peter Hafkemeyer; Hubert E Blum; Heidi Barth; Philipp Henneke; Thomas F Baumert
Journal:  J Innate Immun       Date:  2009-06-23       Impact factor: 7.349

5.  Immunologic characterization of posthepatitis cirrhosis caused by HBV and HCV infection.

Authors:  Wan-Yu Li; Yan-Fang Jiang; Qing-Long Jin; Hong Zhang; Xiang-Wei Feng; Jun-Qi Niu
Journal:  J Biomed Biotechnol       Date:  2010-06-15

Review 6.  The role of infectious agents in the etiology of ocular adnexal neoplasia.

Authors:  Varun Verma; Defen Shen; Pamela C Sieving; Chi-Chao Chan
Journal:  Surv Ophthalmol       Date:  2008 Jul-Aug       Impact factor: 6.048

7.  High interleukin-6 and tumor necrosis factor-alpha serum levels in hepatitis C infection associated or not with mixed cryoglobulinemia.

Authors:  Alessandro Antonelli; Clodoveo Ferri; Silvia Martina Ferrari; Emiliano Ghiri; Santino Marchi; Michele Colaci; Fabrizio Bruschi; Poupak Fallahi
Journal:  Clin Rheumatol       Date:  2009-06-20       Impact factor: 2.980

Review 8.  Direct effects of hepatitis C virus on the lymphoid cells.

Authors:  Yasuteru Kondo; Tooru Shimosegawa
Journal:  World J Gastroenterol       Date:  2013-11-28       Impact factor: 5.742

Review 9.  Between Scylla and Charybdis: the role of the human immune system in the pathogenesis of hepatitis C.

Authors:  Ulrich Spengler; Hans Dieter Nischalke; Jacob Nattermann; Christian P Strassburg
Journal:  World J Gastroenterol       Date:  2013-11-28       Impact factor: 5.742

10.  Defective response to Toll-like receptor 3 and 4 ligands by activated monocytes in chronic hepatitis C virus infection.

Authors:  M C Villacres; O Literat; M DeGiacomo; W Du; T Frederick; A Kovacs
Journal:  J Viral Hepat       Date:  2008-02       Impact factor: 3.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.